{"podcast":{"title":"EP Edge Journal Watch","slug":"ep-edge-journal-watch-7561379","podcast_index_feed_id":7561379,"rss_url":"https://feeds.transistor.fm/ep-edge-journal-watch","website_url":null,"image_url":"https://img.transistorcdn.com/KWuXQ6fPAArQRCgfrqrxfzQNWh_DnAU4t75wkubUSk4/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9jMzFi/ZTYxOTI1M2U4NGRj/OGZmZjBhMDFlMjFm/NDQwMC5wbmc.jpg","author":"Niraj Sharma","episode_count":37,"summary":"Welcome to EP Edge Journal Watch — where cardiac electrophysiology meets evidence, precision, and perspective. Hosted by Dr. Niraj Sharma, this bi-weekly podcast distills high-impact cardiovascular and EP research into clear, clinically meaningful insights. Each episode goes beyond headlines and abstracts to uncover what new studies actually mean for patient care, decision-making, and the future of electrophysiology. What EP Edge Journal Watch stands for: Evidence-based practice Precision electrophysiology A forward-thinking, edge-driven approach to how we interpret and apply data in real-world clinical settings. Whether you’re an electrophysiologist, cardiologist, researcher, trainee, or allied health professional, EP Edge Journal Watch brings you the signal — not the noise. Expect sharp summaries, thoughtful commentary, and practical takeaways designed for the busy clinician who wants to stay ahead of the curve","last_synced_at":"2026-07-20T20:18:25.367003+00:00","page_url":"https://stenobird.com/podcast/ep-edge-journal-watch-7561379"},"episode":{"title":"EP Edge Journal Watch Issue 22: PFA Safety, Lesion Durability, LAAO, Subcutaneous-ICD Testing & AF Ablation Success","slug":"ep-edge-journal-watch-issue-22-pfa-safety-lesion-durability-laao-subcutaneous-icd-testing-af-ablation-success","published_at":"2026-05-18T09:30:00+00:00","page_url":"https://stenobird.com/podcast/ep-edge-journal-watch-7561379/ep-edge-journal-watch-issue-22-pfa-safety-lesion-durability-laao-subcutaneous-icd-testing-af-ablation-success","show_page_url":"https://stenobird.com/podcast/ep-edge-journal-watch-7561379","url":"https://share.transistor.fm/s/6f69b53c","audio_url":"https://media.transistor.fm/6f69b53c/1edbe789.mp3","summary":"In this episode of EP Edge® Journal Watch , Dr. Sharma reviews Issue 22, May 2026, focused on the next phase of electrophysiology: pulsed field ablation safety, lesion durability, long-term AF recurrence, one-stop AF procedures, device simplification, PAC suppression, and the evolving definition of ablation success. This issue begins with the Ferro EHRA 2026 real-world comparison of pulsed field ablation versus radiofrequency ablation for atrial fibrillation, highlighting why PFA safety should be interpreted by endpoint, workflow, platform, and lesion strategy rather than as a single global claim. The episode then examines NAVIGATE-PF Phase 2 , a systematic remapping study of a second-generation, mapping-integrated pentaspline PFA catheter, and what early lesion durability tells us about the future of anatomically accountable PFA. Dr. Sharma also discusses long-term recurrence after pentaspline PFA, including predictors of AF recurrence and what redo procedures reveal about pulmonary vein reconnection among patients with recurrent arrhythmia. Additional studies include concomitant PFA plus left atrial appendage occlusion , exploring whether a one-stop AF strategy may improve procedural efficiency and reduce peridevice leak; PRAETORIAN-DFT , evaluating whether routine defibrillation testing can be omitted after S-ICD implantation when implant position is favorable; and a CT-based risk score for predicting difficult leadless pacemaker implantation . The episode also covers a provocative phase 2 randomized trial of memantine for premature atrial contractions , introducing NMDA receptor antagonism as a potential nontraditional pathway for atrial ectopy suppression. Finally, this issue closes with a critical look at how we define success after AF ablation. Is the traditiona…","meta_description":"In this episode of EP Edge® Journal Watch , Dr. Sharma reviews Issue 22, May 2026, focused on the next phase of electrophysiology: pulsed field ablation s…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2017,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/ep-edge-journal-watch-7561379/episodes/ep-edge-journal-watch-issue-22-pfa-safety-lesion-durability-laao-subcutaneous-icd-testing-af-ablation-success/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/ep-edge-journal-watch-7561379/ep-edge-journal-watch-issue-22-pfa-safety-lesion-durability-laao-subcutaneous-icd-testing-af-ablation-success.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}